TGFB1 and cancer: However, further research is essential to elucidate the systemic characteristics of MYC-targeted inhibition of tumor immune escape, thereby enabling the prediction of the prognosis of MYC-targeted therapy combined with immunotherapy across various cancer types, similar to the TGF-β signaling-related lncRNA signature identified by Wei-wei et al. [40].